From: Health-related quality of life and tuberculosis: a longitudinal cohort study
Participants | Treated for tuberculosis disease | Treated for latent tuberculosis infection | Screened for tuberculosis but healthy and untreated | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
VISIT | BY SEX | N (%) | Mean score (Standard Deviation) | Effect size 1 a | Effect size 2 b | N (%) | Mean score (Standard Deviation) | Effect size 1 a | Effect size 2 b | N (%) | Mean score (Standard Deviation) | Effect size 1 a | Effect size 2 b |
Baseline | Total | 33 | 49.5 (1.3) | - | - | 81 | 50.3 (1.1) | - | - | 91 | 50.2 (0.7) | - | - |
Men | 19 (58) | 49.6 (1.5) | - | - | 37 (46) | 50.2 (0.9) | - | - | 41 (45) | 50.1 (0.6) | - | - | |
Women | 14 (42) | 49.4 (1.2) | - | - | 44 (54) | 50.4 (1.2) | - | - | 50 (55) | 50.3 (0.8) | - | - | |
1 month | Total | 36 | 49.5 (1.0) | 0.0 | - | 58 | 50.2 (0.9) | −0.1 | - | 75 | 50.2 (0.8) | 0.0 | - |
Men | 21 (58) | 49.6 (1.1) | 0.0 | - | 22 (38) | 50.2 (0.6) | 0.1 | - | 38 (51) | 50.2 (0.9) | 0.2 | - | |
Women | 15 (42) | 49.4 (0.8) | 0.0 | - | 36 (62) | 50.2 (1.1) | −0.1 | - | 37 (49) | 50.1 (0.8) | −0.2 | - | |
2 months | Total | 39 | 49.5 (1.0) | 0.0 | 0.0 | 52 | 50.3 (0.8) | 0.0 | 0.1 | 77 | 50.1 (0.8) | −0.1 | 0.0 |
Men | 23 (59) | 49.7 (1.2) | 0.1 | 0.1 | 23 (44) | 50.2 (0.8) | 0.0 | 0.0 | 37 (48) | 50.1 (0.8) | 0.1 | 0.0 | |
Women | 16 (41) | 49.2 (0.5) | −0.2 | −0.2 | 29 (56) | 50.3 (0.8) | 0.0 | 0.1 | 40 (52) | 50.1 (0.8) | −0.2 | 0.0 | |
4 months | Total | 32 | 50.1 (1.2) | 0.5 | 0.5 | 53 | 50.1 (0.8) | −0.2 | −0.2 | 56 | 50.1 (0.7) | −0.1 | 0.0 |
Men | 19 (59) | 50.4 (1.4) | 0.6 | 0.5 | 26 (49) | 50.0 (0.7) | −0.2 | −0.2 | 24 (75) | 50.2 (0.6) | 0.1 | 0.0 | |
Women | 13 (41) | 49.6 (0.4) | 0.3 | 0.8 | 27 (51) | 50.1 (0.8) | −0.2 | −0.2 | 32 (25) | 50.1 (0.7) | −0.2 | −0.1 | |
6 months | Total | 33 | 49.8 (0.6) | 0.4 | −0.2 | 44 | 50.1 (0.7) | −0.2 | 0.0 | 55 | 50.1 (0.9) | −0.1 | −0.1 |
Men | 18 (55) | 50.0 (0.6) | 0.4 | −0.4 | 25 (57) | 50.1 (0.5) | −0.1 | 0.1 | 27 (49) | 50.1 (0.7) | 0.0 | −0.1 | |
Women | 15 (45) | 49.7 (0.5) | 0.3 | 0.2 | 19 (43) | 50.0 (0.9) | −0.4 | −0.2 | 28 (51) | 50. (1.0) | −0.2 | 0.0 | |
9 months | Total | 30 | 49.6 (0.8) | 0.1 | −0.3 | 37 | 50.4 (1.0) | 0.1 | 0.3 | 44 | 50.0 (1.0) | −0.2 | −0.1 |
Men | 18 (60) | 49.5 (0.9) | 0.0 | −0.5 | 20 (54) | 50.3 (0.8) | 0.2 | 0.3 | 18 (44) | 49.7 (0.8) | −0.5 | −0.4 | |
Women | 12 (40) | 49.8 (0.5) | 0.4 | 0.1 | 17 (46) | 50.4 (1.1) | 0.0 | 0.4 | 26 (59) | 50.2 (1.1) | 0.0 | 0.1 | |
12 months | Total | 21 | 49.7 (0.7) | 0.2 | 0.1 | 42 | 50.3 (0.9) | 0.0 | −0.1 | 49 | 49.9 (0.7) | −0.4 | −0.1 |
Men | 13 (62) | 49.7 (0.8) | 0.2 | 0.2 | 21 (50) | 50.4 (0.9) | 0.2 | 0.0 | 23 (47) | 50.0 (0.6) | −0.2 | 0.3 | |
Women | 8 (38) | 49.6 (0.5) | 0.2 | −0.4 | 21 (50) | 50.2 (0.9) | −0.2 | −0.2 | 26 (53) | 49.8 (0.8) | −0.5 | −0.4 |